Suchergebnisse - indolent B‐cell non‐Hodgkin lymphoma

1

High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China

von: Wang, Chaoyu

2017, in: Annals of hematology

Wird geladen...
2

Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study

von: Matsumoto, Yosuke

2019, in: International journal of hematology

Wird geladen...
3

Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan

von: Ogura, Michinori

2016, in: International journal of hematology

Wird geladen...
4

Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites

von: Darwish, Mona

2015, in: Cancer chemotherapy and pharmacology

Wird geladen...
5

Burden of Illness in Follicular Lymphoma with Multiple Lines of Treatment, Italian RWE Analysis

von: Andrés J. M. Ferreri

2023, in: Cancers

Wird geladen...
6

Repeated courses of low‐dose 2 × 2 Gy radiation therapy in patients with indolent B‐cell non‐Hodgkin lymphomas

von: Khalil Saleh

2020, in: Cancer Medicine

Wird geladen...
7

Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential

von: Barrientos JC

2016, in: OncoTargets and Therapy

Wird geladen...
8

Dual PI3Kδγ inhibition demonstrates potent anticancer effects in diffuse large B-cell lymphoma models: Discovery and preclinical characterization of LL-00084282

von: Verma, Mahip K.

2022, in: Biochemical and biophysical research communications

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!